APIs for research and impurities

Please enquire for more information about 3,5-Diiodo-4-hydroxy-DL-phenyllactic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page

N-Methyllidocaine iodide is a drug that is used to treat cardiac arrhythmias. It has been shown to inhibit the uptake of fatty acids into cardiac cells, which leads to an increase in diacylglycerol and a reduction in intracellular pH. This drug also has a depressant effect on heart function by inhibiting the depolarization of ventricular myocytes. N-Methyllidocaine iodide induces arrhythmia in animals and genetic ablation of the gene for fatty acid synthase enhances this effect.

Please enquire for more information about o-Methyl malathion β-monoacid including the price, delivery time and more detailed product information at the technical inquiry form on this page

4-Chloro-3-hydroxybutyric acid (4C3HB) is an analytical, research and development, high purity, synthetic, API impurity and HPLC standard. 4C3HB is a metabolite of the drug clofibric acid. It also serves as an impurity standard for clofibric acid. 4C3HB has been used in the synthesis of some drugs such as risperidone and carbamazepine. The chemical formula for 4C3HB is C9H13ClO2. CAS No. 95574-97-3

AZD8848 is a potent inhibitor of the protein kinase that has been shown to have anticancer properties. This analog of capsaicin has been tested in Chinese hamster ovary (CHO) and human cancer cell lines, where it was found to induce apoptosis and inhibit tumor growth. AZD8848 targets specific kinases involved in cancer cell proliferation and survival, making it a promising candidate for cancer treatment. In addition to its anticancer effects, AZD8848 has also been shown to have potential as a urine protein inhibitor, which could be useful in the diagnosis and monitoring of certain types of cancer. Overall, AZD8848 represents an exciting new avenue for the development of novel anticancer therapies.

Lactiflorin is a natural compound that has been found to have potent inhibitory effects on cancer cells. This medicinal plant extract is commonly used in Chinese traditional medicine as an anticancer agent. Lactiflorin has been shown to induce cell cycle arrest and promote apoptosis in human cancer cells by inhibiting the activity of protein kinases, which are essential for tumor growth and survival. Additionally, lactiflorin analogs have been developed with even greater potency against cancer cells. In preclinical studies, lactiflorin and its derivatives have demonstrated promising results as potential therapeutic inhibitors for various types of cancers. Furthermore, lactiflorin has also shown potential as a non-invasive biomarker for early detection of certain cancers through analysis of urine samples.

Montelukast impurity I is an impurity found in the drug product, Montelukast. It is a natural substance and is produced as a result of metabolism studies. The chemical name for this impurity is 3-hydroxy-4-(2-methylpropyl)-5-(4-methoxyphenyl)pentanoic acid. This impurity can be used as an analytical standard and can be synthesized for use in pharmacopoeia. This compound has not been shown to have any therapeutic effects on humans or animals. This impurity has been shown to cause nausea, vomiting, and diarrhea in some patients.